Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescripti...
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 6, 2025
